The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs.

CONCLUSIONS: Our observations suggest that the Fas signaling pathway may be a common genetic risk factor for SCARs across multiple drugs. PMID: 30088374 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30088374?dopt=Abstract

Source: Allergy, Asthma and Immunology Research - August 10, 2018 Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research